Trump officials exerting unprecedented control over CDC scientific journal
Trump administration political appointees have taken steps in recent weeks to exert unprecedented influence over the Centers for Disease Control and Prevention's flagship medical research publication, the Morbidity and Mortality Weekly Report, multiple federal health officials tell CBS News. The interference included dictating what to cover and withholding studies on the growing bird flu outbreak.
The Trump administration's moves to control the research published by the agency ends a decades-long streak of independence for the journal, known as the MMWR.
Health officials and experts have long considered the MMWR as the "voice of CDC" and a respected source where federal scientists release research of public health importance. It ranks as among the most-cited health journals in the world.
"The MMWR has lost its autonomy," one health official told CBS News.
Efforts by Trump officials to control the publication have stalled the release of three studies about bird flu for weeks, as the virus continues spreading through wild birds, poultry farms and cows around the country.
That delay was initially attributed to the communications "pause" ordered by the Department of Health and Human Services, which stalled many releases across the government.
Spokespeople for the CDC and HHS did not immediately respond to requests for comment.
Trump officials initially said the gag order was needed for the administration to catch up in staffing its public relations team to oversee the vast amount of communications coming out of the nations' federal health agencies.
But as that pause has started to lift, Trump officials at HHS, and acting CDC Director Susan Monarez, refused repeated requests by career health officials to publish the completed research, officials say.
The stalled research includes findings about pet cats owned by dairy workers being infected with bird flu, plus wastewater testing results and antibody testing of cow veterinarians.
Instead, health officials say Monarez relayed orders by the Trump administration to come up with research to publish this week about the health risks from wildfires, days after President Trump criticized California's Democratic Governor Gavin Newsom's handling of fires in the state.
Federal scientists say they scrambled to find studies to comply with the order, which was unexpected and not related to any studies that had been scheduled to come out.
The research that was ultimately published looked at exposure to worrying chemicals for firefighters who responded to the 2023 wildfires in Hawaii and emergency room visits in Los Angeles during the wildfires.
Multiple health officials said they complied fearing their jobs. Scientists within the agency say they have been bombarded with daily requests to accept the "fork in the road" offer to resign by the Trump administration's Department of Government Efficiency, or DOGE, task force, headed by Elon Musk.
Glimpse at a study taken offline
A technical glitch resulted in a table from one of the bird flu studies accidentally being published on Thursday, before officials scrambled to take it down.
That bird flu study was supposed to lay out the details of an investigation into how two indoor cats could have contracted the virus. One of the cats' owners was a dairy worker who transported unpasteurized raw milk, which health officials warn is one of the main ways that H5N1 bird flu virus is spreading between farms in the U.S.
Multiple federal health officials and outside experts have unsuccessfully lobbied the Trump administration to allow the publication to maintain its independence, citing the importance of allowing federal public health researchers to publish their findings without fearing political interference.
While researchers often have to jump through multiple hoops of "clearance" within the agency to satisfy questions and concerns raised by scientists and career health officials about the accuracy of their research, officials said political appointees usually steered clear of meddling in its content.
Now health officials fear that a precedent has been set for the Trump administration to cross further lines in its attempts to influence the research and data published by the CDC.
Previous efforts by Trump-appointed officials to exert control over the publication came under scrutiny during the COVID-19 pandemic, in Mr. Trump's first term, after aides sought to influence reports at the time.
It is now unclear to co-authors of the bird flu research outside the agency when the research will ever be published, weeks after it was ready to go.
"The study is completed and was to be published in MMWR last month until the order from the new administration halted communication from CDC," K. Fred Gingrich II, executive director of the American Association of Bovine Practitioners, said in an email.
The association had worked with Ohio's health department and the CDC to sample the blood of veterinarians who treat cows at an annual conference late last year, looking for antibodies that would help answer an outstanding question: had bird flu cases infected veterinarians under the radar?
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
17 minutes ago
- Medscape
Fast Five Quiz: Opioid Use Disorder
Opioid use disorder (OUD) currently impacts approximately 16 million people worldwide. It is considered a significant public health issue, with experts noting a 'burden that is increasing' globally. As research into optimal management of OUD evolves, updates to clinical guidelines emphasize a more individualized approach to pharmacologic treatment, psychosocial support, and special considerations for specific patient populations, such as pregnant individuals. However, OUD remains a complex disease that comes with many serious health and legal concerns for both patients and clinicians. What do you know about OUD? Check your knowledge with this quick quiz. Despite pharmacologic treatment being known to be highly effective for treating OUD, a CDC report states that 30% of patients with OUD who require OUD treatment received only nonpharmacologic treatment. Further, 43% of patients did not perceive a need for OUD treatment at all. In this significant report, males aged 35-49 years were most likely to receive OUD treatment with medications, while females and younger and older adults had lower rates of access to pharmacologic interventions. The CDC concluded that engaging patients needing OUD treatment with pharmacologic interventions is 'essential.' Learn more about essential statistics for OUD. Data from a predictive-model study indicate that service setting was the strongest predictor for premature discontinuation of OUD treatment. The strength of this predictor declined with length of stay, becoming negligent after 365 days. Other system-level factors such as geographic region, primary source of payment for treatment, and referral source were also strong predictors of early discontinuation; individual factors such as age of first use, sex, and race were less predictive. Previous research cited by the study has also stressed the importance of reducing system-level barriers to care, and the updated federal guidance for opioid treatment programs have expanded access in several ways. Learn more about OUD guidance. Precipitated withdrawal can occur when transferring a patient from methadone to buprenorphine due to buprenorphine being only a partial opioid agonist; as such, the traditional method of transfer involves putting the patient in a controlled, moderate withdrawal state before initiating buprenorphine therapy. However, a novel dosing strategy called microinduction, which involves starting buprenorphine at submilligram doses (or 'low-dose induction'), and cross-tapering with methadone can prevent precipitated withdrawal. Additionally, this method is ideal for patients who want to switch from methadone to buprenorphine and those with chronic use of intravenous or intranasal fentanyl. A recent systematic review found that microinduction and traditional transfer methods had similar rates of successful induction of buprenorphine at 95.6%. Learn more about safe withdrawal practices for OUD. Both the CDC and the latest American Society of Addiction Medicine (ASAM) guidelines specifically state that pharmacotherapy for OUD should be offered as early as possible in pregnancy to prevent harms to both the patient and the fetus, noting that pharmacotherapy for OUD has been associated with improved maternal outcomes. ASAM specifically states, 'increasing the dose or split dosing is often required, especially in the third trimester.' Federal guidelines emphasize that pregnant individuals seeking treatment for OUD are considered a priority for enrollment in opioid treatment programs. Once receiving treatment, they do not generally recommended medically supervised withdrawal from pharmacotherapy for pregnant patients as it might harm the fetus and patient; further, ASAM guidelines state that patients who undergo medically supervised withdrawal are at an increased risk for 'return to opioid use.' However, if a patient decides to proceed with medically supervised withdrawal, ASAM guidelines suggest physicians provide education and resources regarding associated risks. The CDC also specifically recommends against abruptly discontinuing opioids during pregnancy, citing data and resources from the American College of Obstetricians and Gynecologists and the Substance Abuse and Mental Health Services Administration. Learn more about OUD. Federal guidelines specify that opioid treatment programs must conduct at least eight random drug tests per year on their patients. These tests must use FDA approved products that test for commonly abused substances that might affect patient safety, recovery, or adherence to OUD treatment. ASAM affirms this requirement, noting that many patients might need more frequent testing and that eight tests per year 'should be viewed as a minimum.' Learn more about drug testing in OUD. Editor's Note: This article was created using several editorial tools, including generative AI models, as part of the process. Human review and editing of this content were performed prior to publication.
Yahoo
32 minutes ago
- Yahoo
RFK Jr.'s newest CDC vaccine panel includes critics of COVID shots, lockdowns
The Brief U.S. Health Secretary Robert F. Kennedy Jr. has replaced the government's vaccine advisory panel with eight new appointees. The new members include vocal critics of COVID-19 vaccines and pandemic lockdowns, such as Dr. Robert Malone and Dr. Martin Kulldorff. Public health groups have raised concerns that Kennedy's changes could undermine long-standing vaccination policies. NEW YORK - U.S. Health Secretary Robert F. Kennedy Jr. has named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this week. His selections include a scientist who researched mRNA vaccine technology and transformed into a conservative darling for his criticisms of COVID-19 vaccines, and a leading critic of pandemic-era lockdowns. RELATED: RFK Jr. ousts entire CDC vaccine panel Kennedy made the announcement in a social media post on Wednesday. The backstory Kennedy's decision to "retire" the previous 17-member panel was widely decried by doctors' groups and public health organizations, who feared the advisers would be replaced by a group aligned with Kennedy's desire to reassess — and possibly end — longstanding vaccination recommendations. Dig deeper The new appointees to the Advisory Committee on Immunization Practices include Dr. Robert Malone, the former mRNA researcher who emerged as a close adviser to Kennedy during the measles outbreak. Malone, who runs a wellness institute and a popular blog, rose to popularity during the COVID-19 pandemic as he relayed conspiracy theories around the outbreak and the vaccines that followed. He has appeared on podcasts and other conservative news outlets where he's promoted unproven and alternative treatments for measles and COVID-19. He has claimed that millions of Americans were hypnotized into taking the COVID-19 shots. He's even suggested that those vaccines cause a form of AIDS. He's downplayed deaths related to one of the largest measles outbreaks in the U.S. in years. Other appointees include Dr. Martin Kulldorff, a biostatistician and epidemiologist who was a co-author of the Great Barrington Declaration, an October 2020 letter maintaining that pandemic shutdowns were causing irreparable harm. Dr. Cody Meissner, a former ACIP member, also was named. Big picture view The committee, created in 1964, makes recommendations to the director of the Centers for Disease Control and Prevention. CDC directors almost always approve those recommendations on how Food and Drug Administration-cleared vaccines should be used. The CDC's final recommendations are widely heeded by doctors and determine the scope of vaccination programs. The Source The Associated Press contributed to this report. The information in this story comes from a social media announcement made by U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday, in which he introduced eight new members to the federal vaccine advisory panel. This story was reported from Los Angeles.
Yahoo
33 minutes ago
- Yahoo
Kansas faces $3.77B in Medicaid cuts, thousands to lose coverage under Trump's bill: report
KANSAS CITY, Mo. — Kansas will lose more than $3 billion in Medicaid funding, and thousands of Kansans will lose access to health insurance under Trump's proposed bill, according to a new report. New modeling shows 13,000 fewer Kansans would be able to enroll in Medicaid under the 'One Big Beautiful Bill' recently passed by the U.S. House, and the state would lose $3.77 billion in total Medicaid funding. Man charged in death of Platte County sports reporter shot on I-29 The modeling showed $2.29 billion in lost federal Medicaid funding alone—and $3.77 billion when combined with associated state funding losses over a 10-year period. Such losses would likely lead to higher uninsured rates and more financial struggles for rural hospitals already on the brink of closure. These results were recently released by Manatt Health, which conducted the analysis at the request of Kansas health philanthropies United Methodist Health Ministry Fund and REACH Healthcare Foundation. The two organizations wanted to better understand the financial and enrollment impacts of the bill, which would cut $700 billion from Medicaid and is awaiting a vote in the Senate. Medicaid, the public health insurance program that covers more than 366,000 Kansans, is funded jointly by the state and federal government. It provides low-income parents, children, seniors and people with disabilities with health insurance. Adults who do not have children do not qualify for Medicaid in Kansas. 'If this bill passes, it will cause long-lasting harm to thousands of families across Kansas and seriously threaten the survival of rural hospitals across the state,' said Brenda Sharpe, president and CEO at REACH Healthcare Foundation. The analysis shows Kansas will face significant coverage losses and funding reductions over the next 10 years. Manatt said the losses are even greater than shown in the analysis, as data limitations made it unable to model all the provisions in the bill. The estimates do not account for prohibitions on states setting up any new provider taxes or increasing assessments for other providers. That will cause Kansas health care providers, including nursing homes and other health providers, to lose critical funding over time and cause them to become even more financially vulnerable, Manatt said in a news release Wednesday. Coverage losses due to the bill's changes to the Affordable Care Act's Health Insurance Marketplace also couldn't be modeled. However, they will result in additional Kansans losing health insurance, according to Manatt. Not only will the bill remove people's health insurance, it also will remove food assistance. The bill includes $300 billion in cuts from the Supplemental Nutrition Assistance Program (SNAP). 'Congress is trying to rush a plan through the process that will take health care and food assistance away from tens of thousands of Kansans, including children, seniors and people with disabilities,' said David Jordan, president and CEO at the Health Fund. 'At a time when hospitals are trying to keep their doors open and working families are struggling to keep a roof over their heads and food on their tables, we cannot afford these cuts.' Kansas already has more hospitals at risk of closure than any other state in the country. A recent report from the University of Kansas School of Nursing highlights the growing 'maternal care desert' in Kansas. Manatt said 63 rural hospitals are currently at risk, and 87% of Kansas rural hospitals are operating in the red. These hospitals struggle to survive with existing federal funding – and provisions in the bill would cause them to lose billions, making it even harder to stay open. When rural hospitals close, it removes job opportunities and access to health care, creating a ripple effect in small communities, Manatt said. You can read the full report below or by clicking here. Medicaid-Cut-Impacts-to-KansasDownload Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
